About The Study: As of 2023, approximately one-third of U.S. adults met criteria for metabolic syndrome, with overall prevalence showing no significant change between 2013 and 2023. Even though most individual metabolic syndrome components remained largely stable over the past decade, elevation in triglycerides demonstrated a modest increase.
Corresponding Author: To contact the corresponding author, Shady Abohashem, MD, MPH, email sabohashem@mgh.harvard.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.21712)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.21712?guestAccessKey=24881294-1315-4938-bd83-1d596d826579&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121125
JAMA